Sarepta Therapeutics, Inc, a developer of innovative RNA-based therapeutics, announced today that management is scheduled to participate in a fireside chat at the Leerink Partners Rare Disease Roundtable in New York on Wednesday, October 1, 2014, at 8:00 a.m. ET.
In past releases for company presentations the above paragraph is the same and another sentence has always followed in those press releases and is missing in this current one: "Chris Garabedian, Sarepta’s president and chief executive officer, will be the presenter."
Lol, I know it means very little ---- however, it is a change from the 'norm'.